Physician

Deric C. Savior, M.D.

According to 2025 Medicare claims, Deric Savior, M.D. (NPI: 1912183765) practices medical oncology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is ALLIANCE CANCER SPECIALISTS P.C. (NPI: 1487923686; TIN: 452552343) and primary practice location at 19096-3450.

Savior's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 164 traditional Medicare patients, billed 64,134 HCPCS/CPT codes, and received $842,754 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 223 prescription claims across 47 beneficiaries totaling $813,204 in drug costs, led by Tagrisso (Osimertinib Mesylate). 2019 DME data shows 11 claims. Open Payments data shows 223 records totaling $51,672. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $24,835 to $842,754. Similarly, Part D prescription costs have moved sharply higher in recent years, from $102,453 to $813,204. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,385 and ending at $960.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	97	306	$24,835
2016	97	348	$28,947
2017	111	409	$34,659
2018	110	350	$29,582
2019	100	312	$25,255
2020	98	297	$19,563
2021	80	265	$23,379
2022	149	44,935	$564,886
2023	160	66,686	$895,750
2024	164	64,134	$842,754

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	91	592	$102,453
2016	89	408	$40,169
2017	95	472	$62,549
2018	102	625	$149,838
2019	124	652	$202,605
2020	99	623	$359,799
2021	88	487	$635,849
2022	68	266	$655,116
2023	47	170	$274,531
2024	47	223	$813,204

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	26	$1,927
2016	N/R	22	$2,532
2017	N/R	24	$2,650
2018	N/R	24	$2,650
2019	N/R	11	$353
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	38	38	$184
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	40	99	$104
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	88	251	$76
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	31	67	$50
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	69	129	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	26	780	$442,143
Mekinist	Trametinib Dimethyl Sulfoxide	11	330	$176,261
Prochlorperazine Maleate	Prochlorperazine Maleate	23	332	$391
Ondansetron Hcl	Ondansetron Hcl	17	340	$373
Sodium Chloride	0.9 % Sodium Chloride	15	93	$215

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	223	$51,672	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Deric C. Savior, M.D.?

Tedicare shows public-source Medicare data for Deric C. Savior, M.D. (NPI 1912183765), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Deric C. Savior, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Deric C. Savior, M.D.?

Deric C. Savior, M.D. is linked to ALLIANCE CANCER SPECIALISTS P.C. (billing NPI 1487923686) in the available physician profile data.

Does Deric C. Savior, M.D. have Open Payments data?

Deric C. Savior, M.D. has 223 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.